Home › Funds › BEESE FULMER INVESTMENT MANAGEMENT, INC. › ABT

BEESE FULMER INVESTMENT MANAGEMENT, INC. position in ABT

ABBOTT LABORATORIES · Health Care

BEESE FULMER INVESTMENT MANAGEMENT, INC. reported holding 110,703 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$10.9M, representing 0.62% of its reported portfolio and ranking #43 among its reported holdings. BEESE FULMER INVESTMENT MANAGEMENT, INC. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)110.70K sh
Reported value held$10.94M
Portfolio Weight0.62%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BEESE FULMER INVESTMENT MANAGEMENT, INC.'s ABT position evolved

BEESE FULMER INVESTMENT MANAGEMENT, INC. first disclosed a stake in ABT in Q3 2023 at 93,980 shares (US$9.1M). The position peaked in Q3 2025 at 106,588 shares, worth US$14.3M. Across 13 filings, BEESE FULMER INVESTMENT MANAGEMENT, INC. increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 110,703 shares valued at US$10.9M — an increase of 1,473 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 93.98K $9.10M New
Q4 2023 94.39K $10.39M Hold
Q1 2024 95.20K $10.82M Add
Q2 2024 95.89K $9.96M Add
Q3 2024 95.39K $10.88M Reduce
Q4 2024 94.97K $10.74M Hold
Q1 2025 101.42K $13.45M Add
Q2 2025 104.03K $14.15M Add
Q3 2025 106.59K $14.28M Add
Q4 2025 109.49K $13.72M Add
Q1 2026 109.70K $11.26M Hold
Q2 2026 109.23K $9.91M Hold
Q3 2026 110.70K $10.94M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has BEESE FULMER INVESTMENT MANAGEMENT, INC. held ABT?

BEESE FULMER INVESTMENT MANAGEMENT, INC. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BEESE FULMER INVESTMENT MANAGEMENT, INC.'s current position in ABT?

As of Q3 2026, BEESE FULMER INVESTMENT MANAGEMENT, INC. holds 110.70K shares of ABT (ABBOTT LABORATORIES), valued at $10.94M, representing 0.62% of its reported portfolio and ranking #43.

Has BEESE FULMER INVESTMENT MANAGEMENT, INC. been buying or selling ABT?

In the latest 13F filing (Q3 2026), BEESE FULMER INVESTMENT MANAGEMENT, INC. increased its position in ABT. The position peaked in Q3 2025 at 106.59K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.